Preclinical evaluation of new indomethacin-eluting biodegradable urethral stent

Journal of Endourology

Volumn 26, Issue 4, 2012, Pages 387-392

  Kotsar, Andres ^a   Nieminen, Riina ^b   Isotalo, Taina ^c   Mikkonen, Joonas ^b   Uurto, Ilkka ^a   Kellomäki, Minna ^b   Talja, Martti ^c   Moilanen, Eeva ^b   Tammela, Teuvo L J ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c Department of Surgery   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; MONOCYTE CHEMOTACTIC PROTEIN 1; POLYGLACTIN; POLYLACTIC ACID; RANTES; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIODEGRADATION; CALCIFICATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG ELUTING BIODEGRADABLE URETHRAL STENT; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL RABBIT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LOW DRUG DOSE; MALE; NONHUMAN; POLYPOSIS; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPE; STENT;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIODEGRADATION, ENVIRONMENTAL; CELL LINE; CYTOKINES; DRUG EVALUATION, PRECLINICAL; DRUG-ELUTING STENTS; HUMANS; INDOMETHACIN; LACTIC ACID; LIPOPOLYSACCHARIDES; MALE; MICROSCOPY, ELECTRON, SCANNING; POLYGLYCOLIC ACID; POLYMERS; RABBITS; URETHRA;

EID: 84859544765     PISSN: 08927790     EISSN: 1557900X     Source Type: Journal    
DOI: 10.1089/end.2011.0327     Document Type: Article

References (21)

1. McMillan A, Pakianathan M, Mao JH, Macintyre CC. Urethral stricture and urethritis in men in Scotland. Genitourin Med 1994;70:403-405.
2. Andrich DE, Mundy AR. What is the best technique for urethroplasty? Eur Urol 2008;54:1031-1041.
3. Holm-Nielsen A, Schultz A, Moller-Pedersen V. Direct vision internal urethrotomy. A critical review of 365 operations. Br J Urol 1984;56:308-312. (Pubitemid 14123451)
4. Pitkämäki KK, Tammela TL, Kontturi MJ. Recurrence of urethral stricture and late results after optical urethrotomy: Comparison of strictures caused by toxic latex catheters and other causes. Scand J Urol Nephrol 1992;26:327-331. (Pubitemid 23018674)
5. Isotalo T, Tammela TL, Talja M, et al. A bioabsorbable self-expandable, self-reinforced poly-l-lactic acid urethral stent for recurrent urethral strictures: A preliminary report. J Urol 1998;160:2033-2036. (Pubitemid 128703608)
6. Isotalo T, Talja M, Välimaa T, et al. A bioabsorbable self-expandable, self-reinforced poly-L-lactic acid urethral stent for recurrent urethral strictures: Long-term results. J Endourol 2002;16:759-762. (Pubitemid 36077701)
7. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-1780. (Pubitemid 34586912)
8. Laroia ST, Laroia AT. Drug-eluting stents. A review of the current literature. Cardiol Rev 2004;12:37-43. (Pubitemid 38020151)
9. Vogt F, Stein A, Rettemeier G, et al. Long-term assessment of a novel biodegradable paclitaxel-eluting coronary polylactide stent. Eur Heart J 2004;25:1330-1340. (Pubitemid 38998510)
10. Pan M, Suárez de Lezo J, Medina A, et al. Drug-eluting stents for the treatment of bifurcation lesions: A randomized comparison between paclitaxel and sirolimus stents. Am Heart J 2007;153:15.e1-7.
11. Tanaka K, Tanaka H, Kanemoto Y, Tsuboi I. The effects of nonsteroidal anti-inflammatory drugs on immune functions of human peripheral blood mononuclear cells. Immunopharmacology 1998;40:209-217. (Pubitemid 28522179)
12. Mikkonen J, Uurto I, Isotalo T, et al. Drug-eluting bioabsorbable stents - an in vitro study. Acta Biomater 2009;5:2894-2900.
13. Uurto I, Kotsar A, Isotalo T, et al. Tissue biocompatibility of new biodegradable drug-eluting stent materials. J Mater Sci Mater Med 2007;18:1543-1547. (Pubitemid 47030214)
14. Kotsar A, Isotalo T, Uurto I, et al. Urethral in situ biocompatibility of new drug-eluting biodegradable stents: An experimental study in the rabbit. BJU Int 2009;103:1132-1135.
15. Vaajanen A, Nuutinen JP, Isotalo T, et al. Expansion and fixation properties of a new braided biodegradable urethral stent: An experimental study in the rabbit. J Urol 2003;169:1171-1174. (Pubitemid 36188195)
16. Isotalo T, Nuutinen JP, Vaajanen A, et al. Biocompatibility and implantation properties of 2 differently braided, biodegradable, self-reinforced polylactic acid urethral stents: An experimental study in the rabbit. J Urol 2005;174:2401-2404. (Pubitemid 41611837)
17. Kotsar A, Isotalo T, Mikkonen J, et al. A new biodegradable braided self-expandable PLGA prostatic stent: An experimental study in the rabbit. J Endourol 2008;22:1065-1069. (Pubitemid 351693916)
18. Milroy E, Allen A. Long-term results of urolume urethral stent for recurrent urethral strictures. J Urol 1996;155:904-908. (Pubitemid 26052675)
19. Kotsar A, Nieminen R, Isotalo T, et al. Biocompatibility of new drug-eluting biodegradable urethral stent materials. Urology 2010;75:229-234.
20. Castellani ML, Bhattacharya K, Tagen M, et al. Anti-chemokine therapy for inflammatory diseases. Int J Immunopathol Pharmacol 2007;20:447-453. (Pubitemid 47534148)
21. Feitoza CQ, Goncalves GM, Semedo P, et al. Inhibition of COX 1 and 2 prior to renal ischemia/reperfusion injury decreases the development of fibrosis. Mol Med 2008;14:724-730.